Associations of HSD17B1 Gene Expression with its DNA Methylation and Estradiol Level in Polycystic Ovary Syndrome Indonesian Patients
- 1 Doctoral Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
- 2 Human Reproductive, Infertility and Family Planning Cluster, Indonesian Medical Education Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
- 3 Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
- 4 Human Nutrition Research Center, Indonesian Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
- 5 Department of Nutrition, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
- 6 In Vitro Fertilization (IVF) Morula Bunda Jakarta, Indonesian Reproductive Science Institute (IRSI) Bunda Medik Healthcare, Jakarta, Indonesia
- 7 In Vitro Fertilization (IVF) Morula Bunda Jakarta, Indonesian Reproductive Science Institute (IRSI) Bunda Medik Healthcare, Jakarta, Indonesia
- 8 Department of Medical Biology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
Abstract
PCOS's origin and mechanism are still unknown. Epigenetics has been linked to PCOS in an increasing number of studies in recent years. The most extensively researched epigenetic alteration is DNA methylation. During organismal development, DNA methylation can control gene expression by altering transcription factor binding. The alterations in DNA methylation are directly associated with follicular development in PCOS. Studies show that increased levels of pregnenolone and estrogen in the follicular fluid may affect follicle formation in PCOS patients; the process is largely associated with the expression of HSD17B1. There is evidence to suggest that these levels may have an impact on follicle development in PCOS patients. The mechanism for this effect is partially linked to HSD17B1 expression, which catalyzes the final step in estrogen biosynthesis, 17β-estradiol (E2). We speculated that defects in DNA methylation increase gene dysregulation, resulting in decreased mRNA expression of HSD17B1, which eventually generates insufficient E2 in PCOS patients. The objective of this study is to investigate DNA methylation, mRNA expression, and E2 level in PCOS patients and healthy women groups; the correlation between DNA methylation and mRNA expression in PCOS patients; and the correlation between mRNA expression and E2 serum level in PCOS patients. We provided informed consent to participants; we studied 60 female patients, 30 PCOS patients and 30 healthy women served as the control group, we used the Methyl-Specific PCR (MSP) method and quantitative PCR (qPCR) for DNA methylation and mRNA expression analyses, respectively; and we examined E2 serum levels and hormonal levels. The methylation of the HSD17B1 gene in PCOS women was 42.64% and a healthy group showed 53.80% (p = 0.160). The two groups' differences were not statistically significant. The relative expression value of the HSD17B1 gene was 0.70-fold lower compared with the healthy women (p = 0.003) group. Significant variances were between the two groups. The average E2 serum level in the PCOS group is 25.78 pg/mL and in the healthy women group, it is 36.74 pg/mL. Compared to the group of healthy women, the PCOS group had a decreased E2 serum level. The correlation of DNA methylation level versus mRNA expression in PCOS patients is not significant. (p = 0.076). A significant negative association has been seen between the mRNA. There is a significant negative correlation between the mRNA expression of the HSD17B1 gene and serum E2 levels. (p = 0.020). "The more down-regulated mRNA expression of the HSD17B1 gene, the lower serum E2 levels." The integrated analysis in this study was hypomethylated DNA and down-regulated mRNA expression of HSD17B1 genes. The hypomethylated DNA was not involved in down-regulating mRNA expression. Therefore, down-regulated mRNA expression of the HSD17B1 gene in PCOS patients can cause lower E2 levels in PCOS, preventing cell growth and potentially contributing to the cause of PCOS pathogenesis.
DOI: https://doi.org/10.3844/ojbsci.2024.154.169
Copyright: © 2024 Rina Puspita, Andon Hestiantoro, Rina Agustina, Nining Handayani, Batara Immanuel Sirait, Arie Adrianus Polim and Asmarinah. This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- 1,012 Views
- 437 Downloads
- 0 Citations
Download
Keywords
- HSD17B1 Gene
- DNA Methylation
- mRNA Expression
- Estradiol
- Polycystic Ovary Syndrome